Joustra et al.30
|
Level I |
49 |
Nutritional interventions |
Larun et al.28
|
Level I |
1518 |
Exercise therapy |
You et al.31
|
Level I |
1030 |
Systematic review, Chinese moxibustion |
Wang et al.32
|
Level I |
2036 |
Systematic review, high efficacy/poor quality, more frequent treatments than practiced in USA |
Friedberg et al.33
|
Level II |
23 |
Molecular hydrogen, randomized control |
Nilsson et al.34
|
Level II |
62 |
OSU6162 – a monoaminergic stabilizer – randomized control |
Walach et al.35
|
Level II |
409 |
Distant spiritual healing, randomized control |
Crosby et al.36
|
Level IV |
101 |
Retrospective review of Aripiprazole – off-label use |
Fernie et al.37
|
Level IV |
171 |
Cognitive behavioral therapy (CBT) (116) and graded exercise therapy (GET) (55) |
Haghighi et al.38
|
Level IV |
33 |
OSU6162 – a monoaminergic stabilizer |
Kujawski et al.39
|
Level IV |
32/18 |
Whole body cryotherapy and static stretching – case–control |
Nathan and Konynenburg40
|
Level IV |
23 |
Nutritional supplements – full study no longer available online, unable to evaluate if results were beneficial, no control group |
Polo41
|
Level IV |
218 |
Retrospective review of low-dose naltrexone |
Fernandez et al.42
|
Level V |
Review |
Found no curative treatment |
Bjorklund et al.29
|
Level V |
Review |
Nutritional treatment |
Brown43
|
Level V |
Review |
Current treatments modest benefits, poor prognosis, recommends individualized plan |
Mengshoel et al.44
|
Level V |
Review |
Review of nonpharmacological therapies |
Zhang et al.45
|
Level V |
Review |
Reviews Chinese herbs, acupuncture, moxibustion and cupping |
Davenport et al.46
|
Level VI |
Case |
675 days of IV saline |
Royle et al.47
|
Level VI |
Case |
Eye movement desensitization and reprocessing |
Sharpe et al.48
|
Level VII |
Expert Opinion |
Recommend CBT and GET, no known etiology for CFS |
Yancey and Thomas49
|
Level VII |
Expert Opinion |
Only efficacious treatment CBT and GET |